Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
NCT00003685
Adenocarcinoma, Adenocarcinoma of Lung
Calgary, Alberta, Canada
View Trial DetailsNCT Number: NCT07372378
The incidence of lung cancer in China is increasing year by year. Currently, the treatment primarily based on video-assisted thoracoscopic surgery (VATS) is still considered the optimal approach for early-stage non-small cell lung cancer. The widespread application of traditional one-lung ventilation (OLV) technology not only achieves effective lung isolation, but also facilitates exposure of the surgical field during thoracoscopic surgery, making it more convenient for surgeons to operate. However, the occurrence of hypoxemia during one-lung ventilation may pose a risk to patient safety.
One-lung ventilation can lead to increased intrapulmonary shunt, ventilation/perfusion (V/Q) mismatch, and ischemic-hypoxic lung injury. Hypoxemia is the major problem during one-lung ventilation. Postoperative pulmonary complications (PPCs) are among the major complications following thoracic and general anesthesia surgeries, including atelectasis, pneumonia, and respiratory failure, which significantly prolong hospital stay and increase mortality.
Low tidal volume lung-protective ventilation strategies have been widely implemented. Additionally, permissive hypercapnia, reducing peak airway pressure to minimize barotrauma, and decreasing FiO₂ all help reduce pulmonary complications.Recently, researchers have focused on optimizing ventilation strategies during OLV, such as using PEEP or low VT ventilation alone or in combination, or exploring different combinations of tidal volume and respiratory frequency under consistent minute ventilation (VE), aiming to balance lung protection and oxygenation, reduce complications, and improve patient outcomes.
However, to date, there is still no gold standard tidal volume ventilation strategy for reducing pulmonary complications in patients undergoing lung resection.
Trial opening soon.
Get Notified51 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1-7 days after surgery
Postoperative Pulmonary Complications (PPCs): Incidence of any PPC within 7 days postoperatively
Time frame: during surgery
Incidence of hypoxemia: Occurring before the end of surgery
Time frame: through study completion, an average of 1 year
Length of Hospital Stay
Time frame: during surgery
Intraoperative Oxygenation Index
Time frame: during surgery
Intraoperative Lung Compliance
Time frame: during surgery
Intraoperative Driving Pressure
Time frame: during surgery
Intraoperative Dead Space to Tidal Volume Ratio (Vd/Vt)
Time frame: At the end of surgery
The degree of surgeon satisfaction regarding the performance, effectiveness, and experience of a procedure. A 10-point scale is used, 0 indicates complete dissatisfaction and 10 indicates complete satisfaction.
Time frame: through study completion, an average of 1 year
In-hospital mortality
Time frame: 28 day postoperatively
28-day mortality
Time frame: 90 day postoperatively
90-day mortality
Contact information is provided by the study sponsor or research team.
First Affiliated Hospital of Zhejiang University
Other
Association of Various Introperative Tidal Volumes and Postoperative Pulmonary Complications After Video-assisted Thoracic Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00003685
Adenocarcinoma, Adenocarcinoma of Lung
Calgary, Alberta, Canada
View Trial DetailsNCT00363428
Bronchial Neoplasms, Carcinoma, Bronchogenic
Rochester, Minnesota, United States
View Trial DetailsNCT07238582
Blunt Chest Trauma, Fractures, Bone
Samsun, Turkey (Türkiye)
View Trial DetailsNCT07041957
Burn Injury, Burns
Bochum, Germany
View Trial Details